Evidence map›Paper›PMID 40717089›Full record

ArticleScientific reports2025

Fractures incidence and its association on mortality in multiple myeloma patients: a nationwide cohort study (CAREMM-2105 study).

Jeonghoon Ha, Suein Choi, Sung-Soo Park, Seulji Moon, Jinseon Han, Jeongyoon Lee, Ki-Hyun Baek, Seunghoon Han, Chang-Ki Min

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jeonghoon Ha *Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Suein Choi *Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Sung-Soo Park *Division of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. sspark@catholic.ac.kr.
Seulji MoonDepartment of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Jinseon HanDepartment of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Jeongyoon LeeDepartment of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Ki-Hyun BaekDivision of Endocrinology, Stanford University School of Medicine, Stanford, CA, USA.
Seunghoon Han *Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. waystolove@catholic.ac.kr.
Chang-Ki MinDivision of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Funding

Ministry of Food and Drug Safety RS-2023-00216446
6 · The paper itself

Abstract

Multiple myeloma (MM) is known to compromise bone integrity, leading to an increased risk of fractures, which compromise the quality of life and increase mortality rates. This study investigated the incidence of fractures in MM patients and explored the association between fractures after MM diagnosis and mortality using the Korean National Health Insurance Service database. Fracture incidence was compared between MM patients (n = 9365) and 1:1 matched control group from general population. MM patients demonstrated a significantly higher cumulative incidence of fractures, and vertebral and hip fractures presented a particularly elevated hazard ratio (1.36 [95% CI 1.18-1.55] and 1.47 [95% CI 1.10-1.97], respectively). Furthermore, the presence of fracture within the first year of MM diagnosis were associated with increased mortality (any fracture-HR 1.37 [95% CI 1.19-1.58]; vertebral fractures-HR 1.39 [95% CI 1.19-1.63]; hip fractures-HR 2.46 [95% CI 1.52-3.99]; upper limb fractures-HR 1.94 [95% CI 1.32-2.87]). These results showed an increased risk of fracture and a correlation between fractures and increased mortality in MM patients, with hip fractures notably doubling the mortality risk. These findings underscore the importance of monitoring and managing bone health in MM patients to improve survival outcomes.

Indexed as

Fractures, BoneMultiple MyelomaAdultAgedAged, 80 and overCohort StudiesFemaleHip FracturesHumansIncidenceMaleMiddle AgedRepublic of KoreaRisk FactorsBone healthFractureMortalityMultiple myelomaQuality of life

Identifiers

PMID40717089
PMCPMC12301462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.